جاهز للتشغيل
جاهز للتشغيل
Iran is facing a severe pharmaceutical crisis resulting from the impact of war and sanctions on the medication industry. Over 40 pharmaceutical factories have been damaged due to airstrikes and attacks, and the problem has worsened with drug prices soaring to more than three times their previous levels and shortages in pharmacies. U.S. sanctions, particularly the maritime blockade on the country's ports, have led to a decline in the import of raw materials and shipment transfers. Additionally, air freight costs have increased due to restrictions on airlines. Although Iran produces over 80% of its medicines domestically, heavy reliance on imported raw materials and the escalation of sanctions have caused a decrease in production, further burdening patients and threatening the availability of essential medicines amidst the devaluation of the national currency and rising prices of basic commodities.
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading